Gustafson Kurt A's Form 4 filing
Spectrum Pharmaceuticals Inc (SPPI) · filed Feb 24, 2022
- Accession no.
- 0001209191-22-012804
- Filed
- Feb 24, 2022
- Trade date
- Feb 23-24, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $24.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gustafson Kurt ACIK 0001462354 | Officer (EVP & Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | Common Stock, $0.001 par value | SSaleDisposed | −20,215 | $0.70 | −$14,150.5 | 366,188 | Direct | |
| Feb 24, 2022 | Common Stock, $0.001 par value | SSaleDisposed | −15,958 | $0.64 | −$10,213.12 | 354,230 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.